Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer Cells
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.